Literature DB >> 18983136

Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.

Johanna Jyrkkärinne1, Björn Windshügel, Toni Rönkkö, Anu J Tervo, Jenni Küblbeck, Maija Lahtela-Kakkonen, Wolfgang Sippl, Antti Poso, Paavo Honkakoski.   

Abstract

The human constitutive androstane receptor (CAR, NR1I3) is an important regulator of xenobiotic metabolism and other physiological processes. So far, only few CAR agonists are known and no explicit mechanism has been proposed for their action. Thus, we aimed to generate a 3D QSAR model that could explain the molecular determinants of CAR agonist action. To obtain a sufficient number of agonists that cover a wide range of activity, we applied a virtual screening approach using both structure- and ligand-based methods. We identified 27 novel human CAR agonists on which a 3D QSAR model was generated. The model, complemented by coregulator recruitment and mutagenesis results, suggests a potential activation mechanism for human CAR and may serve to predict potential activation of CAR for compounds emerging from drug development projects or for chemicals undergoing toxicological risk assessment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983136     DOI: 10.1021/jm800731b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Evolutionary history and functional characterization of the amphibian xenosensor CAR.

Authors:  Marianne Mathäs; Oliver Burk; Huan Qiu; Christian Nusshag; Ute Gödtel-Armbrust; Dorothea Baranyai; Shiwei Deng; Kristin Römer; Dieudonné Nem; Björn Windshügel; Leszek Wojnowski
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  Rational quantitative structure-activity relationship (RQSAR) screen for PXR and CAR isoform-specific nuclear receptor ligands.

Authors:  Ann M Dring; Linnea E Anderson; Saima Qamar; Matthew A Stoner
Journal:  Chem Biol Interact       Date:  2010-10-20       Impact factor: 5.192

3.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

4.  Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.

Authors:  Bryan Mackowiak; Linhao Li; Matthew A Welch; Daochuan Li; Jace W Jones; Scott Heyward; Maureen A Kane; Peter W Swaan; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2017-04-25       Impact factor: 4.436

5.  Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches.

Authors:  Caitlin Lynch; Yongmei Pan; Linhao Li; Stephen S Ferguson; Menghang Xia; Peter W Swaan; Hongbing Wang
Journal:  Pharm Res       Date:  2012-10-23       Impact factor: 4.200

Review 6.  Role of CAR and PXR in xenobiotic sensing and metabolism.

Authors:  Yue-Ming Wang; Su Sien Ong; Sergio C Chai; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-05-03       Impact factor: 4.481

7.  Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening.

Authors:  Yongmei Pan; Linhao Li; Gregory Kim; Sean Ekins; Hongbing Wang; Peter W Swaan
Journal:  Drug Metab Dispos       Date:  2010-11-10       Impact factor: 3.922

Review 8.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

Review 9.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

10.  Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoforms.

Authors:  O Burk; R Piedade; L Ghebreghiorghis; J T Fait; A K Nussler; J P Gil; B Windshügel; M Schwab
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.